Sodium Phenylbutyrate Attenuates Cisplatin-Induced Acute Kidney Injury Through Inhibition of Pyruvate Dehydrogenase Kinase 4
<b>Background/Objectives:</b> Cisplatin nephrotoxicity is a significant clinical issue, and currently, no approved drug exists to prevent cisplatin-induced acute kidney injury (AKI). This study investigated whether sodium phenylbutyrate (4-PBA), a chemical chaperone, can prevent cisplati...
Saved in:
Main Authors: | Chang Joo Oh, Wooyoung Choi, Ha Young Lee, In-Kyu Lee, Min-Ji Kim, Jae-Han Jeon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/12/2815 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MiR‐5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer
by: Yongchang Miao, et al.
Published: (2020-10-01) -
Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis
by: Alia Khalil, et al.
Published: (2025-01-01) -
Acetylation-Mediated Post-Translational Modification of Pyruvate Dehydrogenase Plays a Critical Role in the Regulation of the Cellular Acetylome During Metabolic Stress
by: Aishwarya Rajakumar, et al.
Published: (2024-12-01) -
Contents of plasma М2-pyruvate kinase (M2-РК) in patients with inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2010-11-01) -
Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency
by: Erin Zagadailov, et al.
Published: (2024-12-01)